Drug Research
Metrics Contract Services Enters Partnership to Develop Oncology Drug
Metrics Contract Services, the US-based contract pharmaceutical development and manufacturing division of Mayne Pharma, announced the signing of a development and manufacturing agreement with ESSA...
Drug Research
Pistoia Alliance President Warns Pharmaceutical Industry Not to Undo...
Tackling global public health crises will require industry to continue overcoming trust issues and accelerate the safe sharing of anonymized patient data
Dr Steve Arlington, President...
Drug Research
Syntegon and Vetter win PDA Drug Delivery Innovation Award...
Together with Vetter, an international pharmaceutical service provider for injectables, Syntegon (formerly Bosch Packaging Technology) has won the PDA Drug Delivery Innovation Award. In the...
Drug Research
Moderna Announces European Medicines Agency Authorizes Third Dose of...
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines announced that the European Medicines Agency (EMA) has authorized a third dose of...
Drug Research
TriLink BioTechnologies Extends EyeGene Partnership for COVID-19 Vaccine Development...
TriLink BioTechnologies, a Maravai LifeSciences company and a leader in the production of nucleic acids for research, diagnostics and therapeutics applications, announced that it expects...
Drug Research
Clarity and Evergreen enter Targeted Copper Theranostics manufacturing agreement...
Clarity Pharmaceuticals, an Australian-based clinical stage radiopharmaceutical company developing next-generation products to address the growing need in oncology, and Evergreen Theragnostics, Inc., a radiopharmaceutical contract...
Drug Research
Merck Licenses Foundational CRISPR Technology to Cellecta, Paving Path...
Merck, a leading science and technology company, announced that its Life Science business sector has signed an agreement licensing its patented CRISPR-Cas9 technology to Cellecta,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.